Targeted Strategies for Today's Evolving Markets

MissionIR Blog

SenesTech Inc. (NASDAQ: SNES) Reports Major Ramp-Up for its Latest Rodent Birth Control Product Amid Strong Demand for Non-lethal Pest Control

  • Pest management professionals nationwide are reporting a continuing climb in rodent responses, with 70 percent increase in northeastern states complaint calls during 2023
  • Arizona-based SenesTech Inc. is reporting success in delivering a non-lethal rodent control alternative to poisons that adversely affect non-target animals and people
  • SenesTech has already gained attention among consumers with its liquid formulation  birth control product that is more humane and effective for reducing rat populations
  • Most importantly, the company recently introduced its Evolve(TM) Soft Bait non-liquid fertility product for the vast professional market that demands non-liquid products, and SenesTech is doubling its production as a result of this rapidly growing professional demand

Rodent pest management enterprise SenesTech (NASDAQ: SNES) is doubling the weekly production of its novel new solution for reducing rat populations with plans to soon double it again in order to keep pace with burgeoning demand, the Phoenix-based company announced in a news release this month.

SenesTech’s Evolve(TM) Soft Bait has seen “substantial initial orders” since its launch in November as a soft bait non-liquid alternative to its popular ContraPest(R) liquid formulation, both of which provide a decrease in the pest population by inducing birth control in rats instead of using poisonous agents that may be a danger to people or animals.

“Since offering my clients ContraPest, it has given them a sense of relief to a never-ending problem … too many rats,” New Hampshire-based pest management professional (“PMP”) Wendy Berry states in the news release ( “Clients have seen huge differences before and after the introduction of ContraPest. They also see how reducing the reproduction rate is a key component to success. With the effectiveness now well known, we have received contracts with a college, municipalities and other downtown areas. Adding Evolve will better meet the needs of my customers.”

The company reports that legislators and other officials in New England are searching for alternatives to traditional poisons known as second-generation anticoagulants (“SGARs”) in the region.

“In Massachusetts, joint bills (H.825 and S.487), which ban the use of SGARs from publicly owned properties such as elementary schools, have continued addressing secondary poisoning problems plaguing the region,” the news release adds — a response to news that three eagles have died of poisoning as the secondary result of SGAR use.

Pest Management Technology’s 2023 “State of the Rodent Control Market” reports that rodent activity continued to climb in 2023, with 60 percent of PMPs reporting increases in rodent infestations over the past year and another 38 percent stating infestations held steady.

“Rats and mice are truly on a tear in the Northeast, where 70 percent of PMPs reported increasing numbers,” the industry publication states (, citing one PMP who has seen rodent-related service calls increase to year-round levels compared to a decade ago and spread to the suburbs over the past five or six years.

The publication also reported 65 percent of PMPs in western states reported rising rodent infestations, indicating the need for better rodent control exist nationwide and not only in one sector of the country. 

SenesTech’s Evolve(TM) Soft Bait has gained attention as the first and only soft bait product featuring technology that targets rodent populations by using non-lethal methods to restrict fertility, filling a growing consumer need with a novel approach.

“The reaction to the launch of Evolve has been enthusiastic and immediate. Within days of launch, we received pallet-sized orders for Evolve from a number of distributors,” SenesTech president and CEO Joel Fruendt stated. “Many of the initial orders are from customers with prior, successful experience with ContraPest(R), our first fertility control product, but who wanted a soft bait product. Evolve has similar efficacy to ContraPest, in a format that is easier to deploy, and at a price point comparable to alternatives such as poisons.”

ContraPest(R) and Evolve(TM) are the first, and still the only, rat contraceptives for restricting fertility in both male and female rats, according to the company.

For more information, visit the company’s website at

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at

About MissionIR

MissionIR (“MIR”) is a specialized communications platform with a focus on assisting IR firms with syndicated content to enhance the visibility of private and public companies within the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, MIR is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, MIR brings its clients unparalleled recognition and brand awareness.

MIR is where breaking news, insightful content and actionable information converge.

For more information, please visit

Please see full terms of use and disclaimers on the MissionIR website applicable to all content provided by MIR, wherever published or re-published:

Los Angeles, CA
310.299.1717 Office
[email protected]

MissionIR is powered by IBN

This entry was posted in SenesTech Inc. SNES. Bookmark the permalink.

Comments are closed.